Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
multiple sclerosis/oksendamine
Link salvestatakse lõikelauale
Leht 1 alates 178 tulemused
Multiple sclerosis with intractable vomiting and atypical area postrema lesion
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Background: Area postrema syndrome is considered as one of the most typical presentations of neuromyelitis optica spectrum disorders (NMOSDs) (Wingerchuk et al., 2015). The involvement of area postrema is rarely seen in multiple sclerosis
Nausea, vomiting and diarrhea: an unusual presentation of multiple sclerosis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The case of a young woman who presented with nausea, vomiting and diarrhea is outlined; the etiology turned out to be a first attack of multiple sclerosis. Plausible mechanisms are discussed.
The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present paper describes the historical use of cannabis, starting with its use in Assyria and China. Recent advances in the understanding of the molecular basis of cannabis action are explained, including the identification of the cannabinoid receptors CB(1) and CB(2), as well as the isolation of
[A case of relapsing multiple sclerosis presenting with only autonomic symptoms including orthostatic hypotension, hiccups and vomiting].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A 49-year-old woman, with a two-year-history of multiple screlosis (MS), noticed postural dizziness, intractable hiccups and vomiting. On admission, she had mild quadriparesis, hypesthesia below the C5 level, and a girdle sensation at the T5 and L1 levels. A CSF examination showed slight increases
Hiccups and vomiting as initial manifestations of multiple sclerosis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The safety profile of cyclophosphamide in multiple sclerosis therapy.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Cyclophosphamide (Cyc) is an alkylating agent used to treat malignancies and autoimmune diseases, such as lupus nephritis, rheumatoid arthritis and immune-mediated neuropathies. Over the past 40 years, Cyc has also been applied to treat multiple sclerosis (MS) and the effective stabilisation of
Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Background: Mitoxantrone (MTX) has been used as an effective disease modifying treatment (DMT) in multiple sclerosis (MS). Evidence from studies demonstrates benefits of reduced relapse rates, MRI disease activity and disability
Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
One hundred sixty-four patients with chronic progressive multiple sclerosis (MS) have been treated with a regimen of high-dose IV cyclophosphamide and ACTH over the past 6 years. Their status was reviewed to determine complications associated with treatment, dosage of medication used to induce a
Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: A case report.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
INTRODUCTION
We present a case of meningitis caused by Cryptococcus neoformans var. grubii in a 46-year old non-HIV-infected patient with multiple sclerosis, treated with dimethyl fumarate monotherapy. We identified no other risk factors for developing cryptococcal meningitis.Multiple sclerosis as a cause of the acute vestibular syndrome.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Multiple sclerosis (MS) causes dizziness and vertigo. Reports suggest responsible lesions are often in the intra-pontine 8th nerve fascicle. We sought to determine frequency and clinical features of demyelinating acute vestibular syndrome (AVS). This is a prospective observational study (1999-2011).
[Successful treatment with additional plasmapheresis for the exacerbation of acute neurological symptoms in a girl with multiple sclerosis].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Few studies have indicated the efficacy of plasmapheresis in children with multiple sclerosis (MS). We report a 10-year-old girl with MS who was successfully treated with plasmapheresis. She experienced the first episode (vomiting and unconsciousness) at the age of eight years. After two years and
[A case of multiple sclerosis with intractable hiccups and sleep apnea syndrome].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A 48-year-old female with multiple sclerosis (MS) accompanied by intractable hiccups of over one month' duration and the sleep apnea syndrome was reported. This MS patient had been well controlled until September 16, 1991 when she experienced nausea, vomiting and hiccups. The patient was admitted to
Cyclophosphamide in chronic progressive multiple sclerosis. Maintenance vs nonmaintenance therapy.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Twenty-seven patients with chronic progressive multiple sclerosis were treated with high-dose intravenous cyclophosphamide induction on either an impatient or outpatient basis. Following induction, patients were randomized to alternate-month outpatient "maintenance" or "no maintenance" therapy.
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
